This announcement is a separate document:
派林生物：北京市嘉源律师事务所关于派斯双林生物制药股份有限公司注销2020年股票期权与限制性股票激励计划已授予到期未行权股票期权的法律意见书
Pacific Shuanglin Bio-pharmacy: Legal opinion of Jia Yuan Law Firm, Peking, on the cancellation of the 2020 stock options and restrictive stock incentive plan of Paz Pharmaceutics Co., Ltd. that have expired but not yet exercised.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.